Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Cash flows from operating activities:
Net income	$ (10,225)	$ 6,134
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Accretion of marketable securities, net		(76)
Impairment on mortgage securities		325
Amortization of intangible assets	1,194	1,194
Amortization of debt discount	1,262
Realized gain on marketable securities		(12,881)
Settlement claims		1,012
Depreciation expense	27	334
Loss on disposal of fixed assets	9
Lease expense	(5)
Goodwill impairment	4,300	0
Compensation recognized under stock compensation plans	224	187
Changes in operating assets and liabilities:
Accounts and unbilled receivables	(461)	1,800
Accounts payable and accrued expenses	(146)	(2,012)
Accrued compensation and benefits payable	(14)	(1,482)
Accrued health and wellness program payable	492
Accrued interest payable	(754)	245
Accrued claim settlements	(459)
Other current assets and liabilities, net	(186)	128
Other noncurrent assets and liabilities, net	(426)	36
Net cash used in operating activities	(5,168)	(5,056)
Cash flows from investing activities:
Proceeds from sales and maturities of marketable securities		13,031
Purchase of property and equipment	(96)
Proceeds from sale of property and equipment	26
Net cash provided by (used in) investing activities	(70)	13,031
Cash flows from financing activities:
Borrowings under revolving line of credit	8,685	55,537
Repayments of borrowings under revolving line of credit	(10,633)	(56,922)
Paydowns of long-term debt	(31)	(81)
Net cash used in financing activities	(1,979)	(1,466)
Net increase (decrease) in cash and cash equivalents	(7,217)	6,509
Cash and cash equivalents, beginning of period	9,249	2,740
Cash and cash equivalents, end of period	2,032	9,249
Supplemental disclosure of cash flow information:
Cash paid for interest	4,030	5,034
Cash paid for reorganization items	94	1,175
Cash paid for income taxes, net	30	75
Supplemental disclosure of non-cash investing and financing activities:
Issuance of common stock in restructure of debt (Note 8)	311
Issuance of common stock warrants in restructure of debt (Note 8)	$ 605